| 000 | 01474 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516025210.0 | ||
| 264 | 0 | _c20120227 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/ar3271 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Quan-Zhen | |
| 245 | 0 | 0 |
_aRisk factors for ANA positivity in healthy persons. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _cMar 2011 |
||
| 300 |
_aR38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aAutoantigens _ximmunology |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xgenetics |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aKarp, David R | |
| 700 | 1 | _aQuan, Jiexia | |
| 700 | 1 | _aBranch, Valerie K | |
| 700 | 1 | _aZhou, Jinchun | |
| 700 | 1 | _aLian, Yun | |
| 700 | 1 | _aChong, Benjamin F | |
| 700 | 1 | _aWakeland, Edward K | |
| 700 | 1 | _aOlsen, Nancy J | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 13 _gno. 2 _gp. R38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/ar3271 _zAvailable from publisher's website |
| 999 |
_c20640381 _d20640381 |
||